Presentation is loading. Please wait.

Presentation is loading. Please wait.

P3.02c-076 Correlation of Neutrophil to Lymphocyte Ratio (NLR) with Clinical Benefit from Checkpoint Inhibitors in Advanced Lung Cancer  Alona Zer, Mike.

Similar presentations


Presentation on theme: "P3.02c-076 Correlation of Neutrophil to Lymphocyte Ratio (NLR) with Clinical Benefit from Checkpoint Inhibitors in Advanced Lung Cancer  Alona Zer, Mike."— Presentation transcript:

1 P3.02c-076 Correlation of Neutrophil to Lymphocyte Ratio (NLR) with Clinical Benefit from Checkpoint Inhibitors in Advanced Lung Cancer  Alona Zer, Mike Sung, Kanwalpreet Walia, Leila Khoja, Manjula Maganti, Catherine Labbe, Frances Shepherd, Penelope Bradbury, Ronald Feld, Geoffrey Liu, Melissa Iazzi, Dianne Zawisza, Nazanin Nouriany, Natasha Leighl  Journal of Thoracic Oncology  Volume 12, Issue 1, Pages S1323-S1324 (January 2017) DOI: /j.jtho Copyright © Terms and Conditions

2 Journal of Thoracic Oncology 2017 12, S1323-S1324DOI: (10.1016/j.jtho.2016.11.1872)
Copyright © Terms and Conditions


Download ppt "P3.02c-076 Correlation of Neutrophil to Lymphocyte Ratio (NLR) with Clinical Benefit from Checkpoint Inhibitors in Advanced Lung Cancer  Alona Zer, Mike."

Similar presentations


Ads by Google